SynthesisThe oncologist2012

Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.

Ann Van Driessche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.